Letter: Comparing first-line infliximab and vedolizumab for ulcerative colitis-it depends on how you use the drug. Authors' reply.
Saved in:
| Title: | Letter: Comparing first-line infliximab and vedolizumab for ulcerative colitis-it depends on how you use the drug. Authors' reply. |
|---|---|
| Authors: | Bokemeyer B; Interdisciplinary Crohn Colitis Centre Minden, Minden, Germany.; Department of Medicine I, UKSH, Kiel University, Kiel, Germany.; Competence Network IBD, Kiel, Germany., Plachta-Danielzik S; Competence Network IBD, Kiel, Germany. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jan; Vol. 59 (1), pp. 142-143. Date of Electronic Publication: 2023 Nov 04. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
